Antibiotic Prescriptions Associated With COVID-19 Outpatient Visits Among Medicare Beneficiaries, April 2020 to April 2021
- PMID: 35394497
- PMCID: PMC8994157
- DOI: 10.1001/jama.2022.5471
Antibiotic Prescriptions Associated With COVID-19 Outpatient Visits Among Medicare Beneficiaries, April 2020 to April 2021
Abstract
This study of Medicare claims data examines the prescribing of antibiotics to older US patients who had outpatient visits for COVID-19 in an effort to address unnecessary antibiotic use for viral infections.
Conflict of interest statement
Figures
References
-
- Bosworth A, Ruhter J, Samson LW, et al. . Medicare beneficiary use of telehealth visits: early data from the start of COVID-19 pandemic. Assistant Secretary for Planning and Evaluation. Published July 28, 2020. Accessed January 31, 2022. https://aspe.hhs.gov/sites/default/files/migrated_legacy_files//198331/h...
-
- Butler CC, Dorward J, Yu L, et al. ; PRINCIPLE Trial Collaborative Group . Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet. 2021;397(10279):1063-1074. doi:10.1016/S0140-6736(21)00461-X - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
